Lithium supplements, typically sold as lithium orotate or lithium aspartate, are taken at low doses (5 to 20 mg daily) for mood support, cognitive protection, and general brain health. Unlike prescription lithium used to treat bipolar disorder, these over-the-counter versions deliver a fraction of the dose and don’t require blood monitoring at typical supplement levels. The evidence behind them is growing but still mostly comes from animal studies, epidemiological data, and small clinical trials rather than large-scale human research.
Mood Support and Emotional Stability
Prescription lithium has been a first-line mood stabilizer for bipolar disorder for decades, backed by extensive clinical evidence. The supplement version piggybacks on this reputation, and there is some supporting science. A systematic review of low-dose lithium interventions found significant benefits for reducing symptoms of depression and mania when used alongside other treatments. The key word there is “alongside.” Low-dose lithium appears most promising as an add-on to existing therapy rather than a standalone fix for serious mood disorders.
A survey of people buying lithium as a supplement found the most common form was lithium aspartate at 10 mg once per day, with doses typically ranging from 5 to 20 mg. For comparison, prescription lithium carbonate is dosed at 600 to 1,800 mg daily. Supplement users are getting roughly 1% of the pharmaceutical dose, which makes dramatic mood-stabilizing effects unlikely on their own but may still nudge brain chemistry in a favorable direction for people dealing with everyday irritability, stress reactivity, or mild mood fluctuations.
Brain Protection and Cognitive Decline
This is where the research gets particularly interesting. NIH-funded research found that people with mild cognitive impairment and Alzheimer’s disease had significantly lower lithium levels in the prefrontal cortex compared to people with normal cognition. Lithium was also found concentrated inside amyloid plaques, the protein clumps associated with Alzheimer’s, suggesting the plaques essentially trap lithium and pull it away from surrounding brain tissue.
In mouse studies, animals fed a low-lithium diet developed more amyloid plaques, more tau tangles (another hallmark of Alzheimer’s), and measurable memory loss. When researchers supplemented those animals with lithium orotate specifically, it reduced plaque burden, reversed synapse loss, and restored memory. Notably, lithium carbonate (the prescription form) did not achieve the same results in that study, which is one reason the orotate form gets so much attention in supplement circles.
A systematic review of low-dose lithium in humans echoed these findings, identifying significant benefits for slowing cognitive decline compared to placebo. The researchers described the pro-cognitive effects and safety profile as opening “promising avenues in the field of neurodegeneration.” This doesn’t mean lithium supplements prevent Alzheimer’s, but the direction of the evidence is consistent across multiple types of studies.
How Lithium Works in the Brain
Lithium’s effects trace back to a single enzyme it blocks: GSK-3. This enzyme plays a role in inflammation, cell survival, and the growth of new brain connections. When lithium inhibits GSK-3, it sets off a chain reaction that increases production of BDNF, a protein often called “fertilizer for the brain” because it supports the growth and survival of neurons. Research in rat brain cells showed that therapeutic concentrations of lithium significantly increased BDNF production through a specific gene pathway.
Blocking GSK-3 also promotes the formation of new blood vessels in the brain and reduces damage from inflammation. In rodent stroke models, lithium treatment after the injury reduced the size of brain damage and improved functional recovery. These neuroprotective effects are why lithium keeps appearing in research on aging, brain injury, and neurodegeneration.
Lithium in Drinking Water and Suicide Rates
Some of the most compelling population-level evidence comes from studies measuring trace lithium in public water supplies. Regions with naturally higher lithium in tap water consistently show lower suicide rates. A study published in the British Journal of Psychiatry analyzed lithium concentrations across regions and found a statistically significant inverse relationship between water lithium levels and suicide mortality, particularly in men. The average lithium content in these water supplies was tiny: around 0.010 mg per liter.
Similar patterns have been observed in Japan, though not every study replicates the finding. Research in parts of England and Greece found no significant association. Still, the consistency of the overall trend across multiple countries has fueled interest in whether even trace amounts of lithium have a meaningful impact on mental health at the population level.
Anti-Aging and Cellular Health
Lithium treatment has repeatedly shown anti-aging effects in preclinical research. One mechanism involves telomeres, the protective caps on chromosomes that shorten as cells age. In rat studies, lithium increased the activity of telomerase, the enzyme that rebuilds telomeres, specifically in the hippocampus (the brain’s memory center). A separate study using a mouse model of Alzheimer’s found longer telomeres in brain tissue after eight months of lithium treatment.
Lithium also appears to boost mitochondrial function, which is the energy-production system inside every cell. Declining mitochondrial performance is a hallmark of aging. Studies in both animals and humans with bipolar disorder have shown that lithium upregulates mitochondrial activity and reduces oxidative stress, the type of cellular damage that accumulates over a lifetime and contributes to age-related disease.
Safety at Supplement Doses
The safety concerns that surround prescription lithium, particularly kidney damage and thyroid suppression, are dose-dependent. At low blood levels (below 0.5 mEq/L), the average increase in thyroid-stimulating hormone was just 0.52 mIU/L, a relatively small shift. At standard maintenance doses for bipolar disorder, that increase doubled to 1.01 mIU/L, and at anti-manic doses it jumped to 2.16 mIU/L. Low-dose lithium does not carry the same renal, toxicity, or tolerability problems seen at prescription levels, though thyroid monitoring is still reasonable if you plan to take it long-term.
The most common supplement dose of 5 to 20 mg of elemental lithium daily falls well below prescription thresholds. In the survey of supplement users, the average daily dose was about 13 mg, with a range from less than 1 mg to 60 mg.
Medication Interactions to Watch For
Even at low doses, lithium can interact with several common medications. The most significant interactions involve:
- ACE inhibitors and ARBs (blood pressure medications like lisinopril or losartan), which can increase lithium levels in the blood and raise the risk of toxicity.
- Diuretics, especially thiazide types (hydrochlorothiazide), which reduce lithium clearance and cause levels to build up. Loop diuretics and potassium-sparing diuretics can also alter lithium concentrations.
- NSAIDs (ibuprofen, naproxen), which reduce the kidneys’ ability to clear lithium. People taking lithium are generally advised to avoid NSAIDs entirely.
If you take any blood pressure medication, water pill, or rely on over-the-counter pain relievers like ibuprofen, the interaction risk is real even with supplement-level doses of lithium. Acetaminophen (Tylenol) is not on the interaction list and is a safer alternative for pain relief.